BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, June 4, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 6, 2018
View Archived Issues
Anti-IL-23 therapy with mirikizumab shows activity in ulcerative colitis trial
Read More
FDA grants QIDP designation to PLG-0206 as a treatment for prosthetic joint infection
Read More
Anti-IL-15 monoclonal antibody AMG-714 shows proof-of-concept in celiac disease trials
Read More
EMA grants PRIME designation to AT-132 for the treatment of X-linked myotubular myopathy
Read More
FDA grants approval for a new indication for Alimta
Read More
Initial phase Ib results of Hu5F9-G4 with rituximab in relapsed/refractory NHL
Read More
First clinical data reported for PLX-9486 in GIST, solid tumors
Read More
Korea Research Institute of Chemical Technology identifies DAPK2 inhibitors
Read More
Hookipa and Gilead to collaborate on development of immunotherapies against HIV and hepatitis B
Read More
Phase II data demonstrate elenbecestat treatment leads to significant effect on Abeta in the brain
Read More
MONALEESA-3, CDK4/6 inhibition with ribociclib in the de novo metastatic breast cancer setting
Read More
Ionis and Biogen close strategic collaboration to develop antisense drugs for neurological diseases
Read More
Spyryx presents positive data for first cohort of HOPE-1 phase II trial of SPX-101
Read More
Navitor Pharmaceuticals divulges mTOR complex 1 and glucose transport inhibitors
Read More
AbbVie seeks Japanese approval for Humira in hidradenitis suppurativa
Read More
FDA provides feedback for phase III program of efgartigimod in myasthenia gravis
Read More
Kyowa Hakko Kirin, Leo Pharma launch Dovobet gel new formulation for psoriasis vulgaris in Japan
Read More
Independent DMC completes last intermediate review of SCiStar study of AST-OPC1
Read More
Axovant licenses gene therapy for Parkinson's disease from Oxford BioMedica
Read More
Nimbus Therapeutics announces new financing
Read More
EZH2 inhibitors patented by Yangtze River Pharmaceutical, Shanghai Haiyan Pharmaceutical Technology
Read More
Amgen identifies new apelin receptor agonists
Read More
Cognition Therapeutics doses first patient in SNAP study of Elayta
Read More
Merck & Co. describes DGAT-2 inhibitors
Read More
First patient enrolled in phase IIa study of THX-110
Read More
